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Abstract 
Chronic pain is increasingly prevalent and costly and will continue to be with the 
increasing mean age of America’s population.  It is important to identify 
interventions addressing pain-related biopsychosocial aspects.  The purpose of 
the current study was to examine if a single session of specific neurofeedback 
(NF) protocols had an effect on subjective fear and physiological fear-avoidance 
behaviors in relation to pain-related stimuli.  Correlational analyses revealed that 
FPQ-III minor pain scores were negatively associated with total fixation duration 
while looking at pain-related pictures.  One-way ANOVAs revealed differences 
approaching significance for those trained on Left-Hemisphere NF protocols 
compared to those in Sham training for total fixation duration, moderate effect 
sizes were found.  Statistically significant group differences were found for those 
trained on Right-Hemisphere protocols compared to those trained on Left-
Hemisphere protocols for first fixation durations.  Findings support research that 
implicates NF training as a neuromodulation technique for the subjective pain 
experience. 
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Introduction 
Effects of One Neurofeedback Session on Relationship between Fear-Of-Pain 
and Visual Avoidance of Pain 
Chronic pain is an extremely prevalent condition.  It is estimated that 70 
million Americans experience some form of acute, recurrent, or chronic  pain 
each year and that 10 percent of the population report the presence of pain at 
least 100 days a year (Cassidy, Cote, Carroll, & Kristman, 2005; Covington, 
2007). Chronic pain has been revealed to affect healthy, college aged students 
as well.  Hastie, Riley, and Fillingim (2005) found a prevalence rate for painful 
experiences at 50% for their college-aged sample.  Hastie et al. (2005) also 
found that the proportion of participants reporting painful experiences was 
comparable across three ethnic groups including African American, Hispanic, 
and Caucasian.  Kennedy, Kassab, Gilkey, Linnel, and Morris (2008) found 
similar results with an annual prevalence rate of 42.8% for lower back pain in 
college students from a major university in Colorado.  
 Chronic pain complaints result in millions of physician office visits per year 
(Hing, Cherry & Woodwell, 2006), and as many as 150 million lost work days 
(Guo, Tanaka, Halperin, & Cameron, 1999). Chronic pain treatments often 
involve increasing doses of a variety of medications to gain a measure of relief.  
Unfortunately, these current pharmacological treatments are moderately effective
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at best (Turk, Wilson, & Cahana, 2011), and often carry important side effects 
(Noble et al., 2007; Van Tulder, Scholten, Koes, & Deyo, 2000; Verdu, 
Decosterd, Buclin, Stiefel, & Berney, 2008).  As a result, multiple treatment 
alternatives have been proposed.  The Purpose of the current study was to 
explore one of these alternative treatment options, specifically Neurofeedback.
3 
CHAPTER I 
Pain 
 Johannes, Le, Zhou, Johnston, and Dworkin (2010) found a prevalence 
rate of 30% for chronic pain in a nationally representative sample.  Half of those 
who reported having chronic pain also reported daily pain, and average pain 
intensity for the past three months as greater than or equal to 7 on a scale from 1 
to 10.  According to Gaskin and Richard (2012), the total annual cost of pain in 
2010 was $560 to $635 billion with additional health care costs due to pain 
ranging from $261 to $300 billion.  Pain also represents a significant loss in 
productivity in the workforce ranging from $299 to $335 billion annually (Gaskin & 
Richard, 2012).  Chronic pain is an increasingly prevalent and costly condition 
and this trend will continue upward with the ever-increasing average age of 
America’s population (Fredburger et al., 2009)  
 Pain has been defined as “an unpleasant sensory and emotional 
experience associated with actual or potential tissue damage, described in terms 
of such damage” (Merskey & Bogduk, 1994, p. 212).  The function of pain, as an 
aversive experience, can be conceptualized as adaptive and/or protective in 
nature (Asmundson, Parkerson, & D’Ambrosio, 2015).  In other words, the pain
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sensation often draws the attention of the individual to potentially damaging 
stimuli within their environment.  From a learning perspective, pain experiences 
facilitate discrimination and avoidance of any stimulus that may be dangerous to 
the individual or hinder their ability to heal from previous injury.  Therefore, pain 
perception involves not only physiological components but also cognitive and 
emotional components.  
Pain is often differentiated based on the duration of the experience: as 
acute or chronic.  Acute pain is the sensation that comes from activation of 
specialized pain receptors (nociceptors) for a limited time and may or may not be 
associated with significant tissue damage (Dafny, 1997).  Loeser and Melzack 
(1999) described acute pain in relation to the activation of nociceptors at the site 
of local tissue damage as well.  In specific, Authors explain that an injury 
modifies characteristics of the pain receptors, their connections to the central 
nervous system, and the autonomic nervous system within that body region to 
produce an acute pain sensation.  Typically, pain report subsides before the 
organic pathology is eventually resolved.  The direct relation to actual tissue 
damage, and the limited nature of the pain perception and healing process make 
acute pain inherently different from other types of pain, specifically chronic pain 
(Dafny, 1997; Loeser & Melzack, 1999). 
Pain is characterized as chronic when it is present on the individual for at 
least three months (Gatchel et al., 2007).  Chronic pain is also often linked to an 
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inability of the organism to adapt or protect from actual or potential damage 
(Asmundson et al., 2015).  Chronic spine pain, especially, has a high impact on 
the sufferer’s everyday functioning, as a range of their activities are often 
severely limited, leading to difficulties with daily chores, social life, and work 
(Aronoff, 1991; Faucett & McCarthy, 2003; Nurmikko, Nash, & Wiles, 1998). 
Persistent or long-term pain can lead to increased irritability and impatience, 
which could heighten reactivity to daily life stressors (Asmundson et al., 2015).  
Considering this increased reactivity to stressors, those suffering from chronic 
pain tend to develop depression-like symptoms: difficulties with concentration, 
lack of interpersonal interaction, increased fatigue, and isolation (Basbaum, 
Bautista, Scherrer, & Julius, 2009; Basbaum & Woolf, 1999; Burkey, 2014; 
Dafny, 1997).  Subsequently, the peripheral and central nervous systems attempt 
adapt to constant state of stress resulting in an anticipation of future pain-related 
events (Dafny, 1997).  Together, these symptoms make it difficult for those 
suffering from chronic pain to process future pain in a healthy way (Amtmann et 
al., 2015).  In fact, some researchers have found that chronic pain sufferers are 
at a higher risk for developing psychopathologies (Dersh, Gatchel, Polatin, & 
Mayer, 2002).
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Chapter II 
Biological Mechanisms of Pain 
Pain perception starts with a physical process that affect specialized nerve 
fibers, which in turn signal the central nervous system that a painful event has 
occurred (i.e. nociception; Julius & Basbaum, 2001).  Nociception is a group of 
biological processes in response to noxious stimuli and this can be measured 
objectively for every individual (Burkey, 2014).  For nociception to become 
painful, there must be awareness of the elicited stimulus (Julius & Basbaum, 
2001).  Therefore, pain by definition, is affected by not only biological but also 
psychological processes (Gatchel, 2005).  In fact, the pain experience depends 
on variables within everyone, which leads to pain being subjective in nature (i.e., 
each person experiences pain in a unique way) (Gatchel et al., 2007).  The next 
sections describe the process of nociception: 
Nociception 
Peripheral.  The process of nociception starts at the receptor site (or the 
specialized fibers that receive information) usually localized within the peripheral 
nervous system.  The peripheral pathway of pain perception relies heavily on 
information transmitted from nociceptors, which fall within three distinct groups 
(Burkey, 2014; Dafny, 1997).  The largest group of nociceptors, called C-fibers, 
conduct slowly due to unmyelinated axons, and typically respond to thermal, 
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mechanical, or chemical noxious stimuli (Burkey, 2014; Dafny, 1997).  The 
second group of nociceptors, called A-delta fibers, conduct more rapidly because 
of their myelinated axons (Burkey, 2014; Dafny, 1997).  These nociceptors are 
responsible for fast or sharp pain sensations.  The final category of nociceptors, 
referred to as sleeping or silent nociceptors, typically respond only to noxious 
stimuli that falls within extreme ranges of intensity (Burkey, 2014; Dafny, 1997).  
Activation of any of these categories of nociceptors is unpleasant and can 
produce pain (Burkey, 2014; Dafny, 1997).  Continuous or persistent activation of 
nociceptors could cause sensitization (lowering the threshold for activation), 
which could allow for normally inoffensive stimuli to provoke noxious sensations 
(Basbaum et al., 2009; Basbaum & Woolf, 1999). 
 Central.  After activation of peripheral nerve tissue, the afferent 
nociceptive information enters the spinal cord and then the brain.  Afferent spinal 
pathways include the spinothalamic, spinoparabrachio–amygdaloid and 
spinoreticulo–thalamic pathways (Dafny, 1997).  (See Figure 1.  Afferent Spinal 
Pathways).  At the brain level, nociceptive information from the thalamus is 
projected to the insula, anterior cingulate cortex (ACC), primary somatosensory 
cortex (S1) and secondary somatosensory cortex (S2), and the Prefrontal Cortex 
(PFC), whereas information from the amygdala (AMY) is projected to the basal 
ganglia (BG) (Burkey, 2014).  In addition, studies have found a correlation with 
observed lesions on the parietal lobe, and pain perception.  A study by 
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Greenspan et al. (1999) demonstrated that the posterior parietal area (i.e., 
parietal operculum) is important for nociceptive input (as measured by evoked 
potentials, MEG, PET and fMRI) associated with painful stimuli.  Each one of 
these different neural pathways plays an important part in the experience of pain 
(Burkey, 2014). 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 1. Afferent spinal pathways.    
Interpretative studies of these pathways have demonstrated some links 
between these systems and its functionality.  For instance, the somatosensory 
cortices (S1 and S2) encode sensory information from noxious stimuli, including 
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the location and duration of pain (Burkey, 2014).  On the other hand, the insula 
and ACC, most often considered part of the limbic system, are crucial for 
encoding the emotional and motivational (i.e., fight, flight, and freeze) 
components of a painful experience (Lenz, Casey, Jones, & Willis, 2009).  
 Interestingly, researchers have revealed that associated pain-brain 
pathways can be activated without experiencing noxious stimuli (Lenz et al., 
2009).  For example, studies have shown that simply observing another person 
in pain may activate some of these pain-associated brain pathways and this is 
especially the case when the individual is observing a loved one in pain rather 
than a stranger (Burkey, 2014).  This activation of pain-brain pathways without 
any actual nociception could act as a priming mechanism for the brain, which 
could lead to an enhanced pain experience (Basbaum et al., 2009; Basbaum & 
Woolf, 1999) 
 Overall, pain is a subjective experience that may serve a protective 
function under specific circumstances.  In specific, acute pain sensations bring 
awareness to injury and possible tissue damage leading to the pursuit of medical 
attention.  However, pain that is persistent or recurrent for three months or more 
ceases to be protective in nature.  Chronic pain has been found to negatively 
affect activities of daily living and could limit activities such as social life, chores, 
and work.  The process of pain perception begins with the physiological process 
of nociception via specialized pain receptors.  These nociceptors transfer 
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sensory information up the spinal cord through the peripheral nervous system to 
the central nervous system and various neural pathways.  Moreover, research 
has shown that these various neural pathways can be activated by non-noxious 
stimuli, suggesting that some psychological processes may influence pain 
perception.
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Chapter III 
Biopsychosocial Model of Pain 
  Biomedical models of pain assume that recovery from pain/injury occurrs 
after tissue damage has been resolved (Gatchel et al., 2007).  However, many 
studies have demonstrated that some individuals may have no pain with organic 
findings (Melzack & Katz, 2001), while other individuals with no organic findings 
demonstrated disabling pain (Melzack, 1989).  These individual differences in the 
pain perception, recovery, and general pain experience stem from complex 
interactions of biopsychosocial processes (Gatchel et al., 2007).  These complex 
interactions include a multitude of psychosocial factors that increase or decrease 
individual recovery time.  For instance, pain perception and disability can be 
influenced by cognitive, emotional, and social factors as well as the ability to 
cope with any complications related to the injury or recovery from the injury 
(Hawker et al., 2010; Lerman, Rudich, Brill, Shalev & Shahar 2015; Tran et al., 
2015). 
Psychosocial factors  
Depression, anger, and anxiety have all been found to be interconnected with 
chronic pain (Amtmann et al., 2015; Kroenke et al., 2011; Sagheer, Khan, & 
Sharif, 2013).  Studies have shown that these psychological emotions have an 
important role in the pain experience, including, making an individual inclined to
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experience pain, be a cause of pain symptoms, modulate the severity of the pain 
experience (amplify or inhibit), be a consequence of chronic or persistent pain, or 
perpetuate the pain experience (Asmundson et al., 2015).  Numerous studies 
have found that those experiencing chronic pain are at risk of experiencing 
higher levels of anxiety and depression as well (Lerman et al., 2015; Sagheer et 
al., 2013).  In fact, chronic pain patients are at greater risk of developing severe 
psychopathologies (e.g. paranoia, major depressive disorder) (Dersh, Gatchel, 
Polatin, & Mayer, 2002).  
The positive relationship between chronic pain and psychological distress 
could be related to chronic pain being considered a chronic stressor.  The 
primary basis of stress response in any organism is correcting homeostatic 
imbalance (Weissman, 1990).  In other words, pain could be considered an 
actual or perceived threat to an organism that disrupts normal functioning, which 
results in the activation of mechanisms that serve to motivate the restoration of 
basic functioning to normal levels (i.e. homeostatic imbalance; Weissman, 1990).  
Chronic pain produces a multitude of events that can facilitate homeostatic 
imbalance (stress) even after the actual damage has been resolved or in the 
absence of any organic pathology (Weissman, 1990).  This prolonged condition 
of stress can have strong negative effects on the body and could cause a 
mutually reinforcing relationship between pain and stress response (Basbaumet 
al., 2009; Basbaum & Woolf, 1999; Burkey, 2014; Dafny, 1997).  
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In the brain, for instance, pain related stress can cause the hypothalamus 
to activate the pituitary gland that secretes adrenocorticotropic hormone, which 
causes the adrenal cortex to secrete cortisol (Weissman, 1990).  Cortisol 
elevates blood sugar and increases metabolism, which allows for motivation of 
resources to counteract the perceived or real threat and restore balance to the 
system (Weissman, 1990).  Prolonged activation of this system caused by 
chronic pain could have serious negative effects on an individual including 
muscle atrophy, suppression of immune system, alterations of brain structures, 
and impairment of tissue repair and growth (Weissman, 1990).  Concurrently, 
body system changes could serve as priming mechanisms for the development 
and/or maintenance of chronic pain, and in turn, alter an individual’s cognitions 
and behaviors creating a negative feedback loop between actual and perceived 
nociceptive threat (Basbaum et al., 2009; Basbaum & Woolf, 1999).  
The relationship between chronic pain and psychological distress is 
exemplified by studies that have looked at the chronic pain/depression 
comorbidity.  These studies have suggested that 40% - 50% of all chronic pain 
sufferers also suffer from depressive symptoms, but in most cases, the 
epidemiological nature of the relationship between chronic pain and depression 
is still misunderstood (Asmundson et al., 2015).  The direction of this relationship 
is still unclear.  Some studies have revealed that depression can cause chronic 
pain or that chronic pain causes depression, while other studies have shown that 
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they exist within a mutually reinforcing relationship (Asmundson et al., 2015).  In 
a recent meta-analysis, Burke, Mathias, and Denson (2015) found that 
depression was the most commonly assessed psychological dimension within 
chronic pain literature.  Researchers also found moderate to very large effect 
sizes for depression scores of those who had chronic pain.  These scores were 
also consistently statistically significant and negative indicating that those whose 
suffer from chronic pain also had high levels of depression in comparison to 
those who did not have chronic pain. 
In another study, Kroenke et al. (2011) examined the relationship between 
chronic pain and depression in a 12-month longitudinal study with 500 primary 
care patients who had persistent back, hip, or knee pain, and were also enrolled 
in the Stepped Care for Affective Disorders and Musculoskeletal Pain (SCAMP) 
study.  Half of the participants were diagnosed with comorbid depression and the 
other half were non-depressed with similar pain reports.  Participants with 
persistent pain and comorbid depression were randomized to a stepped care 
intervention (n =123) or a treatment as usual condition (n = 127) while non-
depressed patients were followed in parallel cohort.  Researchers assessed 
outcome measures at baseline, three, six, and twelve months and used mixed 
effects model repeated measures (MMRM) multivariable analysis to determine if 
change in pain severity predicted depression severity and vice versa.  Results 
revealed that change in depression was a strong predictor of pain severity and 
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change in pain was an equally strong predictor of depression severity.  Authors 
concluded that pain and depression have equally strong effects on each other 
when assessed longitudinally. 
A longitudinal study by Hawker et al. (2010) examined whether 
osteoarthritis (OA) pain determined depressed mood considering fatigue and 
disability and found that chronic pain predicted future fatigue and disability, which 
in turn predicted depressed mood.  However, researchers also found that 
depressed mood and fatigue were so interrelated that each exacerbated the 
other, and fatigue and disability led to worsening of chronic pain.  Depressed 
mood seemed to indirectly affect severity of chronic pain, which could be said to 
increase the likelihood of future disability and fatigue.  It would seem then, that 
the comorbidity between chronic pain and depression is a dynamic process that 
leads to the worsening of functional outcomes for the individual (Hawker et al., 
2010) 
Chronic Pain and Anxiety 
Conceptually, anxiety is a future-oriented emotional state in response to 
an elusive threat with an unclear source (Leeuw et al., 2006).  Anxiety is often 
associated with preventative and/or hyper-vigilant behavior, which may be 
adaptive in short-term contexts, but is often counterproductive in the long run 
(Asmundson et al., 2015; Leeuw et al., 2006).  In chronic pain specifically, the 
threat (pain) is constantly present, which in turn causes a never-ending cycle of 
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anxiety response and preventative behaviors to avoid pain altogether 
(Asmundson et al., 2015).  The long-term consequences of this cycle could be 
disability and disuse, which could lower the threshold at which later pain would 
be experienced.  Numerous studies have found high levels of anxiety in chronic 
pain sufferers, and evidence that it does have an effect of functional outcomes of 
the individual (Asmundson et al., 2015; Leeuw et al., 2006).  
 Sagheer et al. (2013) conducted a study to examine the prevalence of 
anxiety depression in chronic low back pain patients at a tertiary care center.  A 
total of 140 chronic low back pain patients completed demographic 
questionnaires and The Hospital Anxiety and Depression Scale (HADS).  
Researchers found abnormal levels of anxiety in 77 (55%) patients and 
borderline abnormal levels for anxiety in 54 (38.5%) of patients.  Authors also 
found significant gender differences for levels of anxiety within their sample with 
20 (14.28%) males and 57 (40.71%) females reporting abnormal levels.  Sagheer 
et al. (2013) concluded that individuals with chronic low back pain were at high 
risk for anxiety and the risk was significantly higher for females.  
Amtmann et al. (2015) examined the mediational effects of anxiety, 
fatigue, and sleep on the relationship between chronic pain and depression in 
1,245 participants with multiple sclerosis (MS).  Researchers used cross-
sectional self-report symptoms, quality of life data and structural equation 
modeling to examine the variance in depression stemming from various pain-
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related factors (anxiety, sleep, fatigue).  Authors discovered an adequately fitting 
model of the indirect effects of pain on depression, which accounted for 
approximately 80% of variance in depression.  Researchers concluded that 
higher pain was also associated with greater fatigue, anxiety, and sleep 
disturbance, which in turn was associated higher levels of depression.  
Essentially, high levels of chronic pain, indirect effects of that pain (anxiety), and 
depression were all linked within this study’s sample.  Considering these findings, 
anxiety could have acted as a possible mediator between chronic pain and 
depression.  
In another study, Lerman et al. (2015) examined the longitudinal 
relationship between pain, pain-related disability, and symptoms of anxiety in 428 
individuals with chronic pain receiving treatment at a specialty pain clinic.  
Participants completed questionnaires relating to their pain, state anxiety, and 
pain-related disability at four time points with a mean of 5 months between each 
point.  Researchers used cross-lagged, structural equation modeling to examine 
longitudinal associations between the variables.  More than half of the sample 
reported significant symptoms of anxiety (T1-69%, T2-68%, T3-75%, and T4-
73%) at each of the four measurement points and half of the sample reported 
significant symptoms of both anxiety and pain-related disability at each 
measurement (T1-45%, T2-45%, T3-47%, and T4-48%).  Researchers also 
found that a latent anxiety variable predicted pain and pain related disability, but 
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neither pain nor pain-related disability predicted anxiety.  Authors concluded that 
in adult chronic pain patients, high levels of anxiety may exacerbate pain and 
pain-related disability.  
Tran et al. (2015) examined whether anxiety and pain catastrophizing 
were distinct from each other in relation to functional outcomes in pediatric pain, 
and if they distinctly predict functional outcomes based on age.  In a sample of 
725 children and adolescents, researchers measured pain characteristics, 
anxiety, pain catastrophizing, functional disability, and health-related quality of 
life (HRQOL).  Using structural equation modeling, authors found that anxiety 
and pain catastrophizing were distinct in their sample.  Additionally, anxiety 
predicted HRQOL in children and adolescents, and functional disability in 
adolescents alone.  Based on these findings, fearful personalities could influence 
the way individuals perceive threat as exemplified by a painful stimulus. 
Fear of Pain  
Fear is the emotional reaction to an immediate, identifiable threat, such as 
a dangerous situation or an injury (Leeuw et al., 2006).  Like anxiety, fear is an 
adaptive response that serves to protect from harm by activating the fight or flight 
response (Leeuw et al., 2006).  The three crucial components of fear (perception 
of a stimulus as threatening, increased arousal, and defensive behavior) are 
connected and can fluctuate at different rates (Leeuw et al., 2006).  The fear 
response, specifically defensive escape behaviors, may alleviate fear in the short 
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term, but may also negatively reinforce fear-related behaviors in the future 
(Leeuw et al., 2006).  Abnormally high levels of fear occurring more often may 
lead to a lowered threshold for defensive escape behaviors, which in turn may 
lead to a greater chance of pain related anxiety (Leeuw et al., 2006). 
In relation to fear, the way perceived threat (i.e. pain stimulus) is 
interpreted may lead to two distinct outcomes (Vlaeyen & Linton, 2000).  When 
the pain is perceived as non-threatening (low levels of fear), individuals are more 
likely to maintain regular levels of daily activity, which promotes functional 
recovery (Vlaeyen & Linton, 2000).  This concept was supported by the findings 
of Vowles and Gross (2003), who found that decreased levels of fear-avoidance 
beliefs for work was an important factor for improving physical capability and 
enhanced return to work potential.  However, when pain is interpreted as 
threatening (high levels of fear), typically the case with chronic pain, it could give 
rise to pain-related defensive escape behaviors such as avoidance (Vlaeyen & 
Linton, 2000).  Asmundson and Norton (1995) supported this relationship by 
revealing that chronic back pain patients with high anxiety sensitivity reported 
greater levels of fear of pain and had greater avoidance of activities in 
comparison to those with lower anxiety sensitivity, despite both groups having 
equal pain.  
Keogh, Ellery, Hunt, and Hannet (2001) examined whether fear of pain 
would be related to greater selective attentional bias in favor of pain-related 
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stimuli by exposing participants to varied stimuli in terms of being pain-related, 
socially threatening, or positive.  Researchers found that those with high levels of 
fear of pain displayed a selective attentional bias towards pain-related stimuli 
compared to those who had lower levels of fear of pain.  Researchers concluded 
that these results provide evidence for high levels of fear of pain biasing 
attentional processes, which in turn may make individuals more susceptible to 
negative experiences with pain.  In other words, Keogh et al. (2001) suggested 
that higher levels of fear of pain can bias one’s attention towards pain related 
information, priming them to react negatively to any further pain-related 
stimulation.   
Peters, Vlaeyen, and Weber (2005) investigated the contribution of 
physical pathology, pain-related fear, and catastrophizing cognitions to pain 
intensity and disability in 100 participants with low back pain.  Participants 
completed self-report measures and quantified physical pathology via medical 
charts using the MEDICS procedure.  It was found that pain-related fear 
accounted for 10% of variance in regression models for pain intensity and 
disability.  This means that fear of pain was an important predictor of pain 
intensity.  Researchers concluded that fear of pain could lead to a preoccupation 
with pain and a heightened awareness of pain signals, which in turn could lead to 
increased pain perception.  
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Woby, Watson, Roach, and Urmston (2004) found similar results.  In their 
study, 83 chronic pain participants completed a series of self-report measures 
before they participated in a physical therapist led intervention.  Regression 
analysis indicated that fear-avoidance beliefs about work and physical activity 
were independently associated with levels of disability.  In further analyses, 
researchers found that fear-avoidance beliefs about physical activity were the 
only statistically significant predictor of participants’ levels of disability.  These 
results indicated that those participants who endorsed greater levels of fear-
avoidance beliefs specifically about physical activity tended to report greater 
levels of disability.  Therefore, fear of pain is positively associated greater levels 
of disability (Peters et al., 2005; Woby et al., 2004).  
De Gier, Peters, and Vlaeyen (2003) examined the role of pain related 
fear and attentional processes on tolerance for physical activity in 81 fibromyalgia 
participants.  Researchers had high and low fearful fibromyalgia participants 
perform a physical task, a cognitive (reaction) task, and a dual task that 
combined both physical and cognitive components.  Results revealed that low 
fearful participants demonstrated higher activity tolerance for both single and 
dual conditions.  It was also found that high fearful participants responded slower 
on cognitive reaction time than low fearful participants.  Researchers indicated 
that level of pain-related fear did not significantly affect toleration for physical 
performance task, but it was trending in that direction.  In another more recent 
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study, Niederstrasser et al. (2015) found that pain-related fear affected physical 
perception of pain in 82 healthy university students.  Researchers exposed 
participants to an experimental muscle injury protocol designed to induce pain in 
targeted body regions (left or right arm) and their respective muscle group and 
asked them to complete self-report fear of pain measures.  A day after being 
exposed to this procedure, participants were asked to rate their pain while they 
lifted weighted canisters with both the targeted and non-targeted body regions. 
Niederstrasser et al. (2015) indicated that the experimental pain protocol 
was effective at producing pain, which was indicated by increased pain report for 
the targeted arm during session two.  Although the non-targeted arm was 
unaffected by the pain inducing protocol, pain report for the non-targeted arm 
increased during the canister lift in session two across all lifts at a significantly 
greater rate compared to session one.  That is to say, that an inherently non-
noxious stimulus produced higher levels of verbally reported pain in the non-
targeted arm.  Researchers postulated that interactions between pain report and 
levels of pain-related fear, which were only present during session 2, predicted 
increased pain report.  Interestingly, participants with high and low levels of fear 
reported similar levels of pain during the first session, but only those with higher 
levels of fear reported increased pain in the non-targeted arm.  
Vowles and Gross (2003) also found interesting results in relation to pain-
related fear, fear-avoidance behaviors, and changes in physical capability in their 
23 
study.  In this study, 65 participants with chronic pain complete an 
interdisciplinary functional restoration program and collected pre- and post-
treatment measures of fear-avoidance beliefs (FABQ – Waddell, Newton, 
Henderson, Somerville, & Main, 1993), short form McGill pain questionnaire 
(MPQ-SF; Melzack, 1987), and measures of physical ability for work.  Results 
indicated significant decreases in fear-avoidance beliefs, decreases in pain 
severity, and increased ability for work at post-treatment.  A secondary aspect of 
the study was to examine the validity of measures of fear-avoidance in the 
prediction of actual physical capability for work.  Results revealed that changes in 
fear-avoidance beliefs for work had a meaningful relation to changes in capability 
for work.  These findings suggest that changing fear-avoidance beliefs for work 
was an important factor for improving physical capability and enhanced return to 
work potential.  
 Based on the above findings, fear of pain could have an important effect 
on the cognition and behavior of those who are suffering from pain.  These 
results could be due to that fear of pain can bias attentional processes in favor of 
pain-related stimuli, which could result in greater number of negative experiences 
with pain (Keogh et al., 2001).  Fear of pain could also influence avoidance 
related behaviors, which could lead to greater disability (Peters et al., 2005, 
Woby et al., 2004).  Furthermore, changes in pain-related fear and fear-
avoidance beliefs seemed necessary for increased physical capability and work 
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potential (Vowles & Gross, 2003).  Therefore, it is crucial to identify interventions 
that can contribute to decreasing this detrimental emotional state in individuals 
with pain.
25 
Chapter IV 
Neurofeedback 
QEEG 
EEG is the measure of electrical changes within one or more of the cortical 
regions of the brain via electrodes placed on the scalp (Cannon, 2015; 
Hammond, 2011; Kaiser, 2007).  The Electrodes are placed on specific sites 
according to an International 10-20 system, which divides the skull into 
proportional sections in relation to distinguishable landmarks: dent of the nose, 
protrusion in the back of the head, and preauricular points directly in front of each 
ear (Cannon, 2015; Hammond, 2011; Kaiser, 2007).  For a visual representation 
of the International 10-20 system, see Figure 2.
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Figure 2. The international 10-20 system. 
Each electrode bears a particular label that corresponds to underlying brain 
areas: F for frontal, FP for frontal pole, P for parietal, C for central, T for temporal, 
and O for occipital (Cannon, 2015; Hammond, 2011; Kaiser, 2007).  Sites are 
sequenced numerically from the midline (Z), with odd number on the left 
hemisphere and even numbers on the right hemisphere (Cannon, 2015; 
Hammond, 2011; Kaiser, 2007).  Electrical activity is identified as a difference in 
potential between two electrodes in a grounded system (Cannon, 2015; 
Hammond, 2011; Kaiser, 2007).  This difference in potential can be measured in 
reference to another electrode, usually along the midline (Cz) or a linked ear (A1 
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or A2), this is often referred to as referential recording (Cannon, 2015; 
Hammond, 2011; Kaiser, 2007).  Recordings can also be completed in a bipolar 
manner where electrodes are paired together with no common reference (i.e., 
site F4 is linked to C4; C4 to P4, P4 to O2) (Cannon, 2015; Hammond, 2011; 
Kaiser, 2007).  
The electrical activity or rhythm produced by the brain falls within 
conventional frequency bands measured in cycles per second or hertz (Hz) 
(Cannon, 2015; Hammond, 2011; Kaiser, 2007).  Generally, each frequency 
band has been associated with a particular mental state, such as, Delta activity 
(0.5-3.5Hz), associated with deep sleep (Hammond, 2011); Theta activity (4-8 
Hz), associated with a very relaxed state, sometimes referred to as the twilight 
zone between waking and sleep; Alpha activity (8-12 Hz), associated with a 
relaxed, disengaged state; Sensorimotor rhythm activity (13-15 Hz), associated 
with a relaxed attentive state; Beta activity (13-30 Hz), associated with 
intellectual activity and outward focus; and Gamma activity (30+ Hz), associated 
with intense focus, attention, and with processes that involve multiple brain 
networks communicating with each other (Cannon, 2015; Hammond, 2011; 
Kaiser, 2007). It is important to note, that varying degrees of each of these 
brainwave frequencies have been found to occur simultaneously in different parts 
of the brain for most individuals (Cannon, 2015; Hammond, 2011; Kaiser, 2007).  
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In general, dominant brainwave patterns are an indication of awareness level 
(what is NF) (Cannon, 2015; Hammond, 2011; Kaiser, 2007).  
Quantitative EEG (QEEG) is the sophisticated processing of EEG 
recordings that quantifies the electrical activity gathered from electrodes, which 
can be used to provide numerical values that represent patterns of activity 
occurring in the brain (Kaiser, 2007).  QEEG takes raw brain activity and uses 
mathematical processing to quantify and compare that activity to a large 
normative database of EEG activity (Kaiser, 2007).  QEEG produces standard 
scores for an individual’s brain activity based on the activity of others with the 
same age and gender (Kaiser, 2007).  This process allows for comparison of 
brain activity based on a normative sample (i.e., others that are similar in age 
and gender) (Kaiser, 2007).  It also allows for comparisons of brain activity within 
the same individual (Kaiser, 2007).  A clinician/therapist could complete a QEEG 
assessment at one point and then again at a later point in order to compare the 
scores and ascertain the magnitude and direction of any changes in brain activity 
(Kaiser, 2007).   
Neurofeedback Therapy 
 Neurofeedback Therapy (NFT) is just audio and/or visual feedback based 
on QEEG or brainwave activity (Cannon, 2015; Hammond, 2011).  The process 
for NFT closely resembles the process for gathering EEG or QEEG data, but with 
the addition of providing feedback to the individual whose brainwave activity is 
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being measured (Cannon, 2015; Hammond, 2011).  In a typical training session, 
one or more electrodes are placed on the scalp and the earlobes (Cannon, 2015; 
Hammond, 2011).  The electrodes measure electrical activity occurring at the 
scalp and send this information to a computer program that records that data and 
provides instantaneous audio or visual feedback about EEG activity to the 
individual being trained (Cannon, 2015; Hammond, 2011).  
Typically, participants would not be able to willfully influence their 
brainwave activity because they are not consciously aware of their activity level 
(Cannon, 2015; Hammond, 2011).  However, when participants see or hear a 
representation of their brainwave activity occurring in real-time, it allows them to 
gradually change that activity (Cannon, 2015; Hammond, 2011).  Conceptually, 
this closely relates to operant conditioning, where participants recondition and 
retrain their brainwave activity to match a predetermined criterion (Cannon, 2015; 
Hammond, 2011).  Once this criterion has been met, the participant receives 
rewards in the form of audio and visual feedback (Cannon, 2015; Hammond, 
2011).  For instance,  in one session, a typical participant may receive anywhere 
from 300 to 1500 rewards depending on time-frame, participant variables 
(attention, fatigue level etc.), and criterion difficulty level (Cannon, 2015; 
Hammond, 2011).   
Psychopathologies.  Neurofeedback has been utilized in therapy for 
various disorders with increasing empirical support of its effectiveness compared 
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to other therapies and placebo.  Researchers interested in comparing NFT to 
medication in the treatment of ADD/ADHD have consistently found NFT to 
produce comparable, sometimes superior, improvements in attention and 
concentration compared to taking typical ADD/ADHD medication (Leins et al., 
2007; Rossiter & LaVaque, 1995).  In one study, Rossiter and LaVaque (1995) 
sought to examine the efficacy of 20 sessions of EEG biofeedback in reducing 
ADHD symptoms and to compare the results with psychostimulant medication.  
Researchers compared an EEG group with a matched (age, IQ, gender, and 
diagnosis) stimulant group on the Test of Variables of Attention (TOVA) measure, 
which was administered pre- and post-treatment.  Results indicated that both 
groups improved on TOVA measures of attention, impulsivity, information 
processing, and variability but did not differ from each other on change scores.  
Authors indicated that these findings support EEG biofeedback as an effective 
alternative to stimulant medication for ADHD symptoms. 
In another randomized controlled study, Leins et al. (2007) investigated 
whether neurofeedback treatment lead to an improvement in cognition and 
behavior in 38 participants with ADHD aged 8-13 years-old.  The treatment 
procedure involved three phases of 10 sessions each of Neurofeedback training 
using one of two different protocols: positive and negative slow cortical potential 
shifts (SCPs); suppress Theta (4-8 Hz) while increasing Beta (12-20 Hz).  
Results revealed that both neurofeedback protocols produced improvements in 
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cognition and behavior with effect sizes ranging from small (ES =.34) to large 
(ES= 1.02) and six-month follow-up results that did not differ significantly from 
end-of-treatment results.  Both parents and teachers reported seeing significant 
improvements as well.  These findings support the idea that neurofeedback can 
be used to make meaningful changes in cognition and behavior in a 
developmental disability (ADHD) context.  In fact, after a meta-analysis 
conducted in 2009, researchers concluded that NFT had met criteria for being 
classified as an efficacious and specific treatment for ADD/ADHD (Arns, 
Heinrich, & Strehl, 2014). 
Neurofeedback has been shown to be an effective treatment for 
psychological distress.  For instance, Choobforoushzadeh, Neshat-Doost, 
Molavi, and Abedi (2015) evaluated the effectiveness of NFT in treating 
depression and fatigue in 24 participants with multiple sclerosis (MS) in a 
randomized control study.  Participants were randomized into two groups, 
neurofeedback (16 sessions of NFT) training or treatment as usual and evaluated 
three times (baseline, end of treatment, and two-month follow-up) throughout the 
study using the Fatigue Severity Scale and Depression subscale of the Hospital 
Anxiety and Depression Scale.  Using a repeated measures analysis of variance, 
researchers found that NFT significantly decreased symptoms of depression and 
fatigue compared to the treatment as usual condition, and effects were 
maintained at two-month follow-up. 
32 
In another study, Rice, Blanchard, and Purcell (1993) investigated the 
effectiveness of NFT in 45 participants who had generalized anxiety disorder in 
comparison to a waiting list control group.  Participants were randomly assigned 
to one of four different NFT protocols or a pseudo meditation control condition 
and evaluated on STAI-Trait Anxiety and psychophysiological symptoms using 
the Psychosomatic Symptom Checklist.  Results revealed that all participants 
who received NFT treatment showed significant reduction in anxiety and 
psychophysiological symptoms in comparison to the wait-list, pseudo meditation 
control group and that decreased self-report of anxiety was maintained at six 
weeks follow-up.   
Pain.  Neurofeedback has also been used to treat pain conditions.  In a 
pilot study, Caro and Winter (2011) used NFT in their investigation of how it 
would affect attention and somatic symptoms within a sample of fibromyalgia 
syndrome (FMS) patients with attention problems, as indicated via continuous 
performance test (CPT).  Researchers measured pain, fatigue, psychological 
distress, morning stiffness, and tenderness while having some participants 
complete 40 or more NFT sessions and having another control group who 
received standard medical only.  Those trained with NFT improved their visual, 
but not auditory, attention on CPT measures and also showed improvement in 
tenderness, pain, and fatigue.  Although it was not significant, results also 
revealed a trend toward improved psychological distress and morning stiffness, 
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but only after forty or more session of NFT.  Based on these findings, it seems 
that NFT could be an effective therapy option for those suffering from chronic 
pain as seen in patients with FMS. 
In another study, Kayıran, Dursun, Dursun, Ermutlu, and Karamürsel 
(2010) used a randomized, rater blind study to assess the efficacy of NFT in 36 
participants with FMS.  Researchers randomly divided participants into two 
groups: one group received twenty sessions of NFT (four weeks) and another 
received 10 mg per day of escitalopram (control) for eight weeks.  All participants 
received visual analogue scales for pain and fatigue, Hamilton and Beck 
Depression and Anxiety Inventory Scales, Fibromyalgia Impact Questionnaire 
and Short Form 36 as outcome measures.  Results showed improvements on all 
measures for both groups, but the NFT group showed greater benefits than 
controls (p < .05).  These findings indicate that NFT training had comparable and 
even superior benefits compared to Selective Serotonin Reuptake Inhibitor 
(SSRI) treatment, which is typically used in FMS patients to help with mood and 
fatigue. 
Jensen, Grierson, Tracy-Smith, Bacigalupi, and Othmer (2007) conducted 
a study evaluating the effects of NFT on pain in participants with chronic pain.  
Researchers sought to determine the average decrease in pain, identify the 
percentage of pain decreases that were clinically meaningful, and document 
other benefits of NFT training in a sample of 18 individuals with Complex 
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Regional Pain Syndrome Type 1 (CRPS-I).  Participants were given 0-10 
numerical rating scale measures for pain intensity and other symptoms before 
and after a 30 minute NFT training session.  Researchers also performed a 
series of t-tests to determine the significance of any changes, as well as, 
computed effect sizes and percent change in order to quantify observed 
improvements in symptoms.  Results revealed substantial and significant 
decrease in pain intensity with half of the participants reporting changes that 
were clinically meaningful.  Researchers concluded that many patients who 
receive NFT training report short-term reductions in pain-related symptoms, but 
long-term effects of NFT training for chronic pain requires further research to 
evaluate its effectiveness as a treatment option.
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Chapter V 
Rationale 
Chronic pain is an increasingly prevalent and costly condition and this 
trend will continue upward with the ever-increasing average age of America’s 
population.  Individual differences in pain perception, recovery, and general pain 
experience stem from complex interactions of biopsychosocial processes.  The 
biological aspect of pain perception concludes with the brain analyzing and 
interpreting pain related information that comes from nociceptors in the 
peripheral nervous system.  This pain related information is interpreted in the 
brain in the context of the individual’s current cognitive and affective state and his 
or her environmental surroundings.  
Pain perception becomes a subjective experience, which is dictated 
entirely by individual differences within the biopsychosocial processes.  Research 
has shown that chronic pain is strongly associated with psychological 
components such as: depression, anxiety, stress, and pain-related fear.  These 
psychological aspects of chronic pain interact within the individual to produce 
greater negative functional outcomes and greater chances of disability.  
Therefore, it is important to identify interventions that can help reduce the 
psychological distress that is associated with pain.
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Scientific advances in QEEG technology have made it possible for 
individuals to be aware of their brain activity occurring in real-time.  Using 
Neurofeedback therapy, researchers have found that individuals can change 
their brainwave activity in a therapeutic way.  Neurofeedback has been shown to 
work in various psychological disorders, as well as with chronic pain and pain 
related symptoms.  Unfortunately, there are no studies that have looked at the 
effects of Neurofeedback therapy on fear of pain. 
Purpose  
The purpose of this study was to examine how Neurofeedback may affect 
an element of pain, specifically fear of pain.  In specific, this study sought to 
examine if a single training session on specific neurofeedback protocols had an 
effect on avoidant behavior and interfered with the relationship between 
subjective fear (as measured by scores on the Fear of Pain Questionnaire – III; 
FPQ – III) and physiological fear-avoidance behaviors in relation to pain-related 
stimuli (measured via the Tobii X-260 eye-tracker). 
Hypotheses 
I. Participants in the control group that have high scores on the FPQ-III will 
exhibit more fear-avoidant behaviors as indicated by less and/or shorter 
fixations within pain-related area of interest. 
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II. Individuals trained on neurofeedback targeting Right Hemisphere pain 
pathways will have decreased fear-avoidant visual behaviors when 
compared to Left-Hemisphere protocols and Controls.
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CHAPTER VI 
Methods 
Participants 
The data for the current study was collected from 121 male and female 
undergraduate students studying at a Southwestern University in the United 
States with a final sample of 99 participants.  Participants were screened on 
arrival using a multi-item personal and family history wellness questionnaire that 
covered injury, traumatic brain injury (TBI), multiple conditions known to cause 
persisting pain (carpel tunnel syndrome, recurrent migraines, recurrent back pain 
etc.) prescription drug use, and existing psychiatric and developmental disorders.  
Recruitment for the study was accomplished through an online recruitment 
program used by the university, Sona-Systems. The study was approved by the 
Institutional Review Board (IRB).  Participants were excluded if they had a history 
of seizure or epilepsy (N=3), lack of NF training (N=6), or were missing eye-
tracking data (N=13).  Final sample was 99 participants.     
Materials & Equipment 
FPQ-III. Fear of pain was determined using a 30-item self-report measure 
developed by McNeil and Rainwater, (1998).  The FPQ-III contains short 
sentences describing painful experiences that participants rate on a five-point (1-
5) Likert-type scale.  Participants were asked to rate the degree of fear they
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anticipate experiencing related to the painful event.  Higher scores indicate 
greater fear and lower scoreindicate less fear of pain.  The measure consists of 
ten-item subscales including fears of severe pain, minor pain, and medical pain.  
PCS.  The Pain Catastrophization Scale (PCS) measures the level of 
catastrophic thinking in relation to pain experience with catastrophizing defined 
as “an exaggerated negative mental set brought to bear during actual or 
anticipated painful experience” (Sullivan et al., 1995; Sullivan et al., 2001).  Pain 
Catastrophization as measured by the PCS consists of three main factors.  
These factors are threat magnification, rumination, and learned helplessness.  
The Cronbach alpha index for the total PCS was .93 when measured using a 
sample of 288 college students at a Midwestern university (Osman et al., 1997).  
Researchers measuring reliability across of the magnification subscale on the 
PCS across three studies showed an average of Cronbach’s alpha .74 for 
females, and .71 for males (Osman et al., 1997).  
ASRS v1.1.  The Adult ADHD Self-Report Scale Symptom Checklist 
Version 1.1 (ASRS v1.1) was used to assess for ADHD symptomology.  The 
ASRS v1.1. consists of eighteen items assessing the ADHD DSM-IV-TR criteria.  
Critical items are the core of the ASRS v1.1 Screener.  The  ASRS v1.1 Screener 
also  twelve supplemental questions that align with ADHD symptomatology.  The 
ASRS v1.1 is a 5 point Likert Scale ranging from Never to Very Often.  The 
ASRS has been shown to be valid and reliable within the adolescent and adult 
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populations.  Specifically, Adler et al. (2006) found a high internal consistency 
between the items with a Cronbach a of 0.93 at time 1 and 0.94 at time 2 of the 
study.  Within the adult population, the ASRS was also found to have high 
internal consistency for patient and rater-administered versions of the scale 
(Cronbach’s a 0.88 for patient self-report and 0.89 for rater-administered).   
Neurofeedback.  EEG NFT training was carried out using the using the 
BrainAvatar software and a 19-channel signal amplifier, Discovery 24E from 
Brain Master Technologies, Inc.  Brain Avatar is a single platform that allows for 
patient assessment and training to be blended with EEG (Proler & Bass, 2012).  
EEG data was recorded from four electrodes placed (F3, F4, C3, P4) on the skull 
(10/20 system), with ground and reference electrodes placed on the earlobe. 
Neurofeedback training is achieved by  displaying participant’s real-time brain 
activity to teach self-regulation of brain function.  Brain activity is presented to the 
participants in the form of a visual and auditory stimulus.  For this study, this 
feedback was quantified to determine capacity to train (i.e., Beeps Total).   
Tobii X-260 eye-tracker.  Eye tracking was performed using the Tobii X-
260 eye-tracker (see http://www.tobii.se/).  The Tobii X-260 eye-tacker allowed 
for the mapping of eye movements to various features on the screen during task 
performance.  It is a state of the art eye-tracking device that tracks the eye-
movement of participants in real time and gives data on maintenance of gaze on 
a single location. Areas of interest (AOIs) were generated by a JavaScript 
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application.  This application provided the screen coordinates for each element 
that was of interest for a given image (i.e., pain-related stimuli vs. non-pain-
related stimuli; please see appendix A for examples of these stimuli with outlined 
area of interest). For the purpose of this study, fear-avoidant visual behavior was 
defined as the difference between pain-related and non-pain-related stimuli on 
eye-tracking measures.  Relevant Eye tracking variables examined were Time to 
First Fixation (TFF), First Fixation Duration (FFD), Total Fixation Duration (TFD), 
Fixation Count (FC), and Visit Count (VC).  
Eye-Tracking variables Operational Definitions.  
• TFF is length of time in milliseconds until the participants eye 
fixates on a particular point within an AOI;  
• FFD is defined as the length of time in milliseconds that a fixation 
lasts; 
• TFD is defined as the sum of the duration for all fixations within an 
AOI; 
• FC is the quantified as the number of fixations (i.e. maintaining of 
the visual gaze on a single location for 50-600 ms) within an AOI;  
• VC is defined as the number of visits (i.e. time interval between first 
fixation on active AOI and end of last fixation within same AOI) 
within an AOI.  
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Procedure 
Consent, screening and subject preparation.  Upon arrival, participants 
were informed about the nature of the study and given the informed consent.  If 
they accepted participation, they completed prescreening questionnaires.  
Subjects that reported an injury, drug abuse, any psychiatric disorder, current 
pain, history of chronic pain, or seizures/epilepsy were asked to stop the 
experiment without any penalties.  Those participants that passed the 
prescreening then completed FPQ-III, PCS, and the ASRS v1.1.  After 
completion of questionnaires, participants’ skull was prepared for Neurofeedback 
training.  
Training.  Participants were randomly assigned to one of three 
Neurofeedback groups, 1) the Right Hemisphere training protocol group, 2) the 
Left Hemisphere training protocol, and 3) the Sham condition.  The Right 
Hemisphere protocol consisted of neurofeedback training on locations F4 (GO 
12-15Hz; STOP 20Hz and up) and P4 (GO 4-12Hz; STOP 15Hz and up).  The 
Left Hemisphere protocol consisted of neurofeedback training on locations F3 
(GO 15-20Hz; STOP 4-7Hz and 20Hz and up) and C3 (GO 4-12Hz; STOP 15Hz 
and up).  The Sham protocol consisted of no direct training; instead participants 
watched a pre-recorded “sham” training session.  Feedback was achieved by 
showing the participant their own brain activity.  Such information was presented 
to the participants in the form of auditory and visual feedback (beeps).  
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Regardless of the condition, each participant trained for 30 minutes and received 
continuous auditory and visual reinforcement.  
Pain-relevant visualization task.  After training occurred, participants 
completed the non-pain/pain visualization tasks on the Tobii eye-tracker for a 
total of 5 minutes.  The task was combination of looking at images, either non-
pain-relevant or pain-relevant, and answering questions about those images 
shortly afterwards.  Participants were shown an initial set of 32 non-pain-relevant 
images, each image shown for second. Participants were then shown another 
group of 32 pain-relevant images followed by a series of ten questions about 
details either seen or unseen in the images.  This task was designed to measure 
fear-avoidant behavior (eye movement) in relation to pain-related stimuli.
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CHAPTER VII 
Results  
 Descriptive statistics for the full sample are presented.  The total number 
of participants in the final sample was n = 99.  The final sample Mage = 19.34 
years (SD = 2.04); with a minimum age of 18 and a maximum age of 33.  The 
sample was primarily Caucasian (58.6%, n = 58) followed by Hispanic (24.2%, n 
= 24), African-American (14.1%, n = 14), and Asian/Other (3%, n = 3).  In terms 
of school classification, the sample was mostly Freshmen (58.6%, n = 58) and 
Sophomores (19.2%, n = 19) followed by Juniors (12.1%, n = 12), and 
Senior/Other (10.1%, n = 10).  For gender, the sample had a majority of female 
participants (68.7%, n = 68) followed by male participants (31.3%, n = 31).  
Randomly assigned participants were distributed between the three experimental 
conditions in relatively equal fashion with a slight majority being in the sham 
condition (39.4%, n = 39) followed by left hemisphere condition (29.3%, n = 29), 
and right hemisphere condition (31.3%, n = 31).  Table 1 presents a summary of 
demographic variables divided by participant condition.
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Table 1 
 
Descriptive statistics for final sample divided by participant condition (N = 99) 
 Sham 
n (%) 
Left Hemisphere 
n (%)  
Right Hemisphere  
n (%) 
Total 
n (%) 
Gender     
Female  27 (27.3) 20 (20.2) 21 (21.2) 68 (68.7) 
Male  12 (12.0) 9 (9.0) 10 (10.0) 31 (31.3) 
Classification      
Freshmen 
Sophomore  
Junior 
Senior 
Other 
23 (23.2) 
11 (11.1) 
1 (1.0) 
3 (3.0) 
1 (1.0) 
16 (16.2) 
4 (4.0) 
6 (6.1) 
3 (3.0) 
-- -- 
19 (19.2) 
4 (4.0) 
5 (5.1) 
3 (3.0) 
-- -- 
58 (58.6) 
19 (19.2) 
12 (12.1) 
9 (9.1) 
1 (1.0) 
Ethnicity      
Caucasian  
Hispanic 
African-American 
Asian 
Other  
22 (22.2) 
13 (13.1) 
3 (3.0) 
1 (1.0) 
-- -- 
18 (18.2) 
3 (3.0) 
7 (7.1) 
-- -- 
1 (1.0) 
18 (18.2) 
8 (8.1) 
4 (4.0) 
-- -- 
1 (1.0) 
58 (58.6) 
24 (24.2) 
14 (14.1) 
1 (1.0) 
2 (2.0) 
Note: % = percentage of final sample; n = frequency within sample; Sham = sham NF training 
condition; Left Hemisphere = left hemisphere NF training condition; Right Hemisphere = right 
hemisphere NF training Condition.  
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Table 2 presents the frequency distribution for other possible confounds that 
occurred in the sample.  Frequencies are separated by variable as well as by 
condition.  Across all conditions, 19 participants indicated experiencing a 
concussion at some point in their life with a slight minority (n = 3) occurring in the 
right hemisphere condition.  In terms of chronic pain (pain lasting longer and 
three months), 7 participants indicated that they had experienced chronic pain in 
their lifetime with a majority (n = 5) occurring in the left hemisphere condition.  
Sixteen participants indicated that they had experienced recurrent back pain with 
relatively equal distribution across conditions.  For psychiatric diagnoses, 12 
participants reported having a diagnosis with a slight majority (n = 6) occurring in 
the sham condition.  Eight participants reported having a developmental 
diagnosis equally distributed across conditions.  In terms of taking psychiatric 
drugs during their lifetime, 13 participants reported doing so with a slight majority 
(n = 6) occurring in the sham condition. 
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Table 2 
Frequency of Other Possible Confounds (N = 99)  
 
Sham Training 
n (%) 
Left 
Hemisphere 
Training 
n (%) 
Right 
Hemisphere 
Training 
n (%) 
All Groups 
n (%) 
Concussion      
No 31 (31.3) 21 (21.2) 28 (28.3) 80 (80.8) 
Yes 8 (8.1) 8 (8.1) 3 (3.0) 19 (19.2) 
Chronic Pain     
No 38 (38.4) 24 (24.2) 30 (30.3) 92 (92.9) 
Yes 1 (1.0) 5 (5.1) 1 (1.0) 7 (7.1) 
Recurrent Back Pain     
No 33 (33.3) 23 (23.2) 27 (27.3) 83 (83.8) 
Yes 6 (6.1) 6 (6.1) 4 (4.0) 16 (16.2) 
Psychiatric Diagnosis     
No 33 (33.3) 27 (27.3) 27 (27.3) 87 (87.9) 
Yes 6 (6.1) 2 (2.0) 4 (4.0) 12 (12.1) 
Developmental 
Diagnosis 
    
No 36 (36.4) 26 (26.3) 29 (29.3) 91 (91.9) 
Yes 3 (3.0) 3 (3.0) 2 (2.0) 8 (8.1) 
Taking Psychiatric 
Drugs 
    
No 33 (33.3) 26 (26.3) 27 (27.3) 86 (86.9) 
Yes 6 (6.1) 3 (3.0) 4 (4.0) 13 (13.1) 
Note: % = percentage of final sample; n = frequency within sample; Sham = sham NF 
training condition; Left Hemisphere = left hemisphere NF training condition; Right 
Hemisphere = right hemisphere NF training Condition. 
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A Chi-square analysis was conducted to determine if ethnicity, 
classification, or gender differed across conditions.  Results indicated that 
conditions were very similar in all above demographics (X2(2) < 9.836, p > .28).  
An ANOVA was conducted to determine if age, training, ADHD reported 
symptoms, Pain Catastrophization scores, fear of pain scores (total, minor, 
severe, and medical), or pain sensitivity were significantly different between the 
groups.  Table 3 shows no significant differences between groups in any 
demographic, training, ADHD or fear of pain variables. 
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Table 3 
 
Summary of ANOVA for Differences in Demographic Variables per Condition    
 
Variable Sham Training Left Hemisphere Training  
Right Hemisphere 
Training  
  
 M (SD) M (SD) M (SD) F p 
Age 
 
19.28 
 
(2.97) 
 
19.17 
 
(1.34) 
 
19.29 
 
(2.12) 
 
.082 
 
.922 
 
Beeps Total 
 
- 
 
- 
 
1346.97 
 
(154.15) 
 
1332.00 
 
(137.56) 
 
.260* 
 
.612 
 
ADHD Critical  
 
8.46 
 
(3.97) 
 
8.90 
 
(3.03) 
 
8.87 
 
(3.82) 
 
.156 
 
.855 
 
ADHD Total 
 
28.26 
 
(12.13) 
 
28.72 
 
(9.54) 
 
28.61 
 
(11.18) 
 
.017 
 
.983 
 
PCS Total 
 
12.26 
 
(8.48) 
 
14.62 
 
(10.68) 
 
11.71 
 
(9.35) 
 
.812 
 
.447 
 
Fear-of-Pain: 
Total 
 
84.51 
 
(21.34) 
 
82.90 
 
(22.39) 
 
82.68 
 
(24.10) 
 
.070 
 
.932 
 
Fear-of-Pain: 
Minor 
 
21.87 
 
(8.80) 
 
21.66 
 
(8.38) 
 
20.90 
 
(8.24) 
 
.118 
 
.889 
 
Fear-of-Pain: 
Severe 
 
34.49 
 
(8.44) 
 
34.59 
 
(9.12) 
 
35.16 
 
(8.88) 
 
.056 
 
.945 
 
Fear-of-Pain: 
Medical 
 
28.13 
 
(8.59) 
 
26.69 
 
(8.78) 
 
26.71 
 
(10.02) 
 
.290 
 
.749 
 
Note: * T-test was conducted to determine differences in training rewards (Beeps Total) between 
the left hemisphere training condition and the right hemisphere training condition.  Age = mean 
age of participants in each condition; Beeps Total = mean cumulative rewards (beeps) received 
for participants in each condition; ADHD = Attention Deficit Hyperactivity Disorder; PCS = Pain 
Catastrophization Scale; Fear-of-Pain = total and subscale scores on Fear-of-Pain Questionnaire 
3; Sham = sham NF training condition; Left Hemisphere = left hemisphere NF training condition; 
Right Hemisphere = right hemisphere NF training Condition. 
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Table 4 displays correlations between potential covariates including ADHD 
variables, PCS, FPQ-III scores (i.e., total scores, minor pain scores, severe pain 
scores, and medical pain scores) and fear-avoidant eye behavior (e.g. TFF = 
Time to first fixation; FFD = First fixation duration; TFD = Total fixation duration; 
FC = Fixation count; VC = Visit count) during the pain and no-pain visual stimulus 
for participants in the sham (control) condition only.  This analysis was conducted 
with the sham condition only because it was assumed that participants in this 
group had zero-level of neurofeedback training.  Results of the Pearson 
correlation revealed the following: There were no significant correlations between 
FFD and any other eye-tracking variables or other covariates.  Time to first 
fixation was significantly correlated with both FC and VC.  Fixation count was 
significantly correlated with VC and TFD.  Total fixation duration was the only 
eye-tracking variable that significantly correlated with other covariates, 
specifically the FPQ-III subscale minor pain.  No other eye-tracking variables 
were significantly correlated with any other covariates (i.e., fear-of-pain, PCS, or 
ADHD).  
FPQ-III total scores were significantly correlated with all minor subscales 
including minor pain, severe pain, and medical pain.  Scores on the medical pain 
subscale were also significantly correlated with minor pain subscale and severe 
pain subscale score.  In other covariates, PCS scores significantly correlated with 
FPQ-III total score, minor pain subscale, severe pain subscale, and medical pain 
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subscale as well as ADHD-related scores including critical scores, and total 
scores.  ADHD total scores significantly correlated with minor pain subscale 
scores, and ADHD critical scores. 
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Table 4 
 
Correlation Matrix for Eye-tracking Variables, Fear of Pain Variables, and Other Covariates in the 
Sham (Control) Minus Those Excluded from Group Analysis (N = 38) 
   2 3 4 5 6 7 8 9 10 11 12 
Eye-tracking           
1 TFF .23 .24 -.28* -.44** .09 .09 .06 .08 .09 .05 .05 
2 FFD - -.03 -.13 -.12 -.04 .01 -.05 -.05 .07 -.06 -.06 
3 TFD 
 
- .45** .06 -.05 -.24* .03 .07 .06 .03 .11 
4 FC 
  
- .55** -.15 -.16 -.12 -.11 -.02 -.03 -.03 
5 VC 
   
- -.06 -.17 .04 -.04 -.09 .00 .01 
FPQ-III 
        
 
6 Total  
    
- .80** .88** .88** .37** .07 .17 
7 Minor  
     
- .53** .54** .32** .17 .23* 
8 Severe  
      
- .70** .27** .04 .09 
9 Medical  
       
- .35** .01 .14 
PCS 
        
 
10 Total 
        
- .24* .33** 
ADHD            
11 Critical  
         
- .86** 
12 Total           - 
Note: TFF = Time to first fixation; FFD = First fixation duration; TFD = Total fixation duration; FC = 
Fixation count; VC = Visit count.  All eye-tracking variable scores are the estimated differences 
between pain and no-pain images (e.g., TFF pain - TFF no-pain = TFF).  Fear of pain = scores on 
FPQ-III: Total = total score; Minor = score on minor pain subscale; Severe = score on severe pain 
subscale; Medical = score on medical pain subscale.  PCS = Pain Catastrophization Scale: Total 
= total score.  ADHD = scores on ASRS v1.1: Critical = sum of critical item scores; Total = total.  
** = p < 0.01 (2-tailed); * = p< 0.05 (2-tailed). 
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A number of one-way ANOVAs were conducted to determine the effect of 
training conditions (sham, left hemisphere training, and right hemisphere training) 
on fear-avoidant eye behavior. Fear-avoidant eye behavior, again, was defined 
as the difference between pain-related and non-pain-related stimuli (e.g., fixation 
count on pain-related stimuli – fixation count on non-pain-related stimuli = fixation 
count difference).   Results of the ANOVA indicated significant differences for 
training conditions on FFD difference and marginally significant differences on 
total fixation duration difference.  Post hoc comparisons using the Tukey HSD 
test indicated that the mean first fixation duration difference for the right 
hemisphere training condition was significantly greater than the left hemisphere 
training condition.  However, the sham condition did not significantly differ from 
right hemisphere or left hemisphere training conditions (see Table 5). 
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Table 5  
Group Analysis of Variance for Effect Training Conditions on Fear-avoidant Eye Behavior 
Differences  
 
Sham  
Left  
Hemisphere  
Training 
Right  
Hemisphere 
Training   
Cohen’s d 
 N = 39 N = 29 N = 31    
Fear-Avoidant 
Eye Behavior M (SD) M (SD) M (SD) F P Left Right 
TFF 0.13 (1.04) 0.16 (3.71) -0.12 (3.92) 0.05 .944 .01 -.09 
FFD 0.04 (0.28) -0.05 (0.18) 0.13 (0.30) 3.37 .039 -.37 .31 
TFD  6.57 (9.55) 11.80 (4.36) 9.28 (7.96) 3.07 .052 .67 .30 
FC 12.28 (27.07) 18.82 (26.85) 11.64 (29.06) 0.60 .549 .24 -.05 
VC -3.00 (8.39) -2.78 (9.15) -5.79 (7.36) 1.17 .312 .03 -.35 
Note: Cohen's d = Left and right hemisphere conditions compared to sham condition; All eye-
tracking variables represent differences in those measures on pain vs non-pain related stimuli 
(e.g., TFFpain – TFFnon-pain = TFF); Sham = sham NF training condition; Left Hemisphere = left 
hemisphere NF training condition; Right Hemisphere = right hemisphere NF training Condition. 
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CHAPTER IV 
Discussion 
The purpose of this study was to determine if one session of neurofeedback 
(NF) could affect a subjective pain experience and visual behavior.  In specific, 
this study looked to determine if 30 minutes of hemisphere-specific NF training 
significantly decreased fear-of-pain related avoidant behavior measured via eye-
tracking.   
Relationship between Fear of Pain and Eye-Tracking Variables 
This study found a significant negative correlation between an FPQ-III 
subscale (i.e., minor pain), and the eye-tracking variable total fixation duration 
when participants were looking at pain-related pictures.  This fear-of-pain and 
eye-tracking correlation finding, suggests that selective attentional biases 
towards pain-related stimuli (Keogh et al. 2001) can be measured via eye-
tracking (Bannerman, Milders, & Sahraie, 2010a, 2010b).  This finding is 
supported by Asmundson and Norton (1995) who found that chronic pain 
patients reporting greater levels of fear-of-pain also displayed greater avoidance 
than those with lower levels of fear, even after controlling for perceived level of 
pain.  This finding is also supported by De Gier et al. (2003) who found that 
participants with high pain-related fear differed significantly from their low fear 
counterparts by demonstrating slower reaction times on a cognitive task.
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However, eye-tracking in this sample, did not correlate with report of fear of 
medical injuries.  Considering that our sample is composed of healthy young 
adults, it is possible that participants in the current sample have not been 
exposed to medical conditions that lead to severe pain, and thus, they are less 
avoidant of such images.  This conclusion is supported by early fear acquisition 
models which suggest that previous experiences are crucial for establishing and 
maintaining future fear-related behavior (Mineka & Cook, 1986; Muris, 
Steerneman, Merckelbach, & Meesters, 1996; Rachman, 1977; Rachman, 1991). 
NF training effects on Fixation Duration and Time to First Fixation 
Contrary to what we expected, group analyses revealed that those individuals 
who received Left-Hemisphere NF training had longer Total Fixation Duration 
within pain-related areas of interest than those who received Sham training, 
although results are at the level of approaching statistical significance (p<=.052).  
Effect size for the comparison Left Hemisphere NF training and Sham were 
considerate moderate (d = .67) suggesting possible effects of NF on fear-
avoidance eye-behavior. 
The current study found significant group differences on first fixation duration 
when looking at pain-related pictures.  Specifically, those trained on Right 
Hemisphere NF training protocols held their first visual gaze on a single location 
longer than those trained on Left Hemisphere NF training protocols.  
Interpretation of this finding is difficult given that this eye-tracking measure did 
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not significantly correlate with any measure on the FPQ-III or the ADHD-related 
measure.  It is possible that this finding may reflect an unaccounted-for variable 
within the study such as novelty (i.e., new pain-related features in the second set 
of images), curiosity (i.e., differences in the second set of images lead to 
increased fixations), or other visual perception factors.  However, this is still not 
clear, and future studies are needed to test these possibilities. 
Interpretation of Results 
Our findings seem to support studies that have suggested NF training as a 
neuromodulation technique for reducing the fear of pain in clinical settings.  In 
specific, Jensen et al. (2007) found clinically meaningful decreases in pain 
intensity at primary pain sites for 18 spinal cord injury participants.  Researchers 
found statistically significant improvement on measures of psychological well-
being.  Despite the lack of connection between some fear-of-pain, ADHD-related 
symptoms, and eye-tracking behavior, it is possible that NF training protocols, 
specifically right hemisphere specific protocols influenced attention-related brain 
networks in such a way that resulted in longer first fixation durations within pain-
related stimuli (Gevensleben et. al, 2009a; Gevensleben et. al, 2009b). 
Studies using similar to our NF training protocols, have found evidence of 
significant improvements in attention-related behavior measures in individuals 
diagnosed with ADHD have (Gevensleben et. al, 2009a; Gevensleben et. al, 
2009b).  Specifically, Gevensleben et. al (2009a) found that the improvement for 
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combined NF training group were superior to the placebo group with moderate 
effect sizes (ES = .60).  Effects sizes for NF training on attention-related 
processes, such as the approach explained above, have been reportedly 
comparable to effect sizes reported for pharmacological treatments 
(methylphenidate; ES NF = 0.81 vs. ES methylphenidate = 0.84). These findings 
seem to indicate that NF training protocols targeting specific attention-related 
neural networks result in significant improvements in attentional processes.   
Limitations and Future Studies  
Eye-tracking behavior as measured in the current study failed to 
significantly correlate with overall fear-of-pain scores, ADHD-related scores, and 
scores on the PCS. As such, there is potentially no true relationship between 
eye-tracking measures and behavioral outcome measures in the current study.  
With this initial assumption of relationship not being met, it is difficult to make 
definitive conclusions about the meaning of performance on eye-tracking 
measures in relation to the manipulated variable (i.e., NF training).  Future 
studies should aim to establish connections between measures of eye-tracking 
(e.g., first fixation duration, total fixation duration, and fixation count) and other 
behavioral outcome measures before testing assumed effects on eye-tracking 
measures.  These established relationships could serve as the foundations of 
future predictions about eye-tracking and behavior in response to manipulation of 
independent variables.  
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The current study made use of a convenient sample of healthy college 
students which could result in generalizability issues (i.e., any conclusions made 
are in reference to sample itself and not greater population), under 
representation of sociodemographic differences (misrepresentation of ethnic 
minorities), and introduce modest amounts of variability within groups resulting in 
unpredictable results and inconsistent findings (Bornstein, Jager, & Putnick, 
2013).  This modest variability could have translated to increased variability 
within conditions in the current study resulting in inconsistencies in statistical 
significance and effect sizes (Bornstein et al., 2013).  Future studies could aim to 
decrease within group variability by focusing on a specific target population such 
as those individuals suffering from persistent chronic pain or any other unique 
population.   
In collecting data for the current study, many participants (n = 22) were 
excluded for various reasons including issues with technology, poor effort, and/or 
history of mental or physical health concerns.  Future studies should aim to refine 
data collection procedures using technology such as eye-tracking software to 
decrease the likelihood of lost participant data due to technological difficulties.   
Finally, it is typical for participants to be exposed to multiple NF sessions.  
In the current study, participants were exposed to just one training session which 
may have translated into smaller effect sizes overall.  Future studies should 
examine the cost and benefits of exposing participants to multiple sessions of NF 
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training as a way of ensuring that the appropriate level of effect is achieved in 
order to compare to other similar NF training studies.  
Conclusion  
In the current study, it was found that FPQ-III subscale (minor pain) scores 
were negatively correlated with total fixation duration when participants were 
looking at pain-related pictures suggesting that higher levels of fear of minor pain 
may be associated with attentional biases towards pain-related stimuli.  However, 
other eye-tracking variables measured in the current study showed no significant 
correlations with FPQ-III total scores and medical or severe pain subscale 
scores.  Previous research indicates that these suggested attentional biases may 
be influenced by prior experience which could explain findings in the current 
study. 
Analyses revealed group differences approaching significance for the 
individuals who received Left-Hemisphere NF training compared to those who 
received Sham training for total fixation duration.  Although not significant, effect 
sizes for this for comparison were considered moderate.  There were significant 
group differences found between those trained on Right-Hemisphere NF 
protocols compared to those who received Left-Hemisphere NF training on first 
fixation duration.  However, this finding is difficult to interpret given that first 
fixation duration did not significantly correlate with any FPQ-III measures, ADHD-
related measure, or the PCS measure.  Overall, findings from the current study 
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provide some support for previous research implicating NF training as a 
neuromodulation technique for affecting the subjective pain experience. 
Neurofeedback could potentially be useful to decrease the psychological 
outcome often related to chronic pain.  Validation of this beneficial therapeutic 
approach for chronic pain and related symptoms requires further scrutiny.  
Specific variables related to its effectiveness including behavioral correlates with 
pain-related fear should be examined more closely to determine their relationship 
to the experience of pain and how specific NF training protocols may affect them.
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